Osaka, Japan

Yasuhiro Miyako

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiro Miyako. Retrieved from https://idiyas.com/inventor/yasuhiro-miyako

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuhiro Miyako: Innovator in Injectable Pharmaceutical Formulations

Introduction

Yasuhiro Miyako is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. His innovative work focuses on improving the quality and efficacy of pharmaceutical solutions.

Latest Patents

Yasuhiro Miyako holds 1 patent for his invention titled "Injectable pharmaceutical formulations." This patent addresses a process for suppressing foaming that may occur during the preparation of a solution or suspension. The invention is particularly relevant for pharmaceuticals and foods, as it aims to eliminate disadvantages caused by foaming during preparation.

Career Highlights

Miyako is currently associated with Shionogi Company Limited, a prominent pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to focus on innovative solutions that enhance the quality of injectable medications.

Collaborations

Throughout his career, Yasuhiro has collaborated with esteemed colleagues, including Hideaki Tai and Kazuichi Fujikane. These collaborations have contributed to the advancement of pharmaceutical technologies and the development of effective formulations.

Conclusion

Yasuhiro Miyako's contributions to injectable pharmaceutical formulations demonstrate his commitment to innovation in the pharmaceutical industry. His work not only addresses critical challenges in drug preparation but also enhances the overall quality of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…